Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
174 studies found for:    treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Show Display Options
RSS Create an RSS feed from your search for:
treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Resistance in HIV+ in North and South
Condition: HIV Drug Resistance
Intervention:
2 Recruiting Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Condition: HIV
Interventions: Drug: ibalizumab;   Drug: Optimized Background Regimen
3 Recruiting A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects
Condition: HIV
Interventions: Drug: PRO 140;   Drug: Placebo;   Drug: Optimized Background Regimen
4 Recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
5 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
6 Recruiting Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
Condition: HIV/AIDS
Interventions: Drug: BMS-955176;   Drug: Atazanavir(ATV);   Drug: Ritonavir(RTV);   Drug: Dolutegravir(DTG);   Drug: Tenofovir(TDF)
7 Recruiting Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
Condition: HIV/AIDS
Interventions: Drug: BMS-663068;   Other: Placebo
8 Recruiting Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
Condition: HIV-1 Infection
Intervention: Drug: MK-1439A
9 Recruiting Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa
Conditions: HIV;   AIDS
Intervention: Procedure: HIV-1 RNA Resistance Testing
10 Recruiting Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I
Condition: HIV-1 Infection
Intervention: Drug: E/C/F/TAF
11 Not yet recruiting Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in HIV-Infected and HIV-Uninfected Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: Bedaquiline
12 Recruiting Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study
Condition: HIV
Intervention:
13 Recruiting Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir
14 Recruiting Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings
Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir 50 mg;   Drug: Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg;   Drug: Efavirenz 200 mg
15 Recruiting Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy
Condition: HIV
Intervention:
16 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
17 Not yet recruiting A Randomised Trial of Dolutegravir (DTG)-Based Antiretroviral Therapy vs. Standard of Care (SOC) in Children With HIV Infection Starting First-line or Switching to Second-line ART
Condition: HIV Infection
Intervention: Drug: DTG
18 Recruiting HIV-DNA Dynamics in HIV Monoinfected or HIV/HCV Coinfected Patients
Condition: HIV
Intervention: Procedure: Blood sample withdrawal
19 Recruiting HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
Conditions: HIV Infection;   Stage I Adult Hodgkin Lymphoma;   Stage I Adult Non-Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Adult Non-Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Non-Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Non-Hodgkin Lymphoma
Interventions: Biological: C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs;   Drug: Carmustine;   Biological: Filgrastim;   Other: Laboratory Biomarker Analysis;   Drug: O6-Benzylguanine;   Drug: Plerixafor
20 Not yet recruiting Improving Outcomes With Metformin
Conditions: HIV Infection;   Hepatitis C
Interventions: Drug: Metformin;   Other: No treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.